Sudha Yarlagadda to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Sudha Yarlagadda has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.109
-
CDK4/6 inhibition in early and advanced hormone receptor-positive, HER2-negative breast cancer. Expert Rev Anticancer Ther. 2025 Jun; 25(6):675-686.
Score: 0.109
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.